Astra and Roche Get New Growth Engines as Older Drugs Fade

(Bloomberg) -- New medicines are taking over as the engines of growth at Roche Holding AG and AstraZeneca Plc as sales of aging blockbusters give way to competition from cheaper generics.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.